期刊文献+

宫颈癌组织中Foxm1、ANGPTL4蛋白表达及临床意义 被引量:3

Expression and clinical significance of Foxm1 and ANGPTL4 protein in cervical cancer tissues
下载PDF
导出
摘要 目的:探讨宫颈癌组织中Foxm1、ANGPTL4蛋白表达及临床意义。方法:选取2017年1月-2018年3月河南省人民医院保存的宫颈癌组织标本72例,同时选取正常宫颈组织标本35例作为对照组,采用免疫组化检测Foxm1、ANGPTL4蛋白表达水平。结果:宫颈癌组织Foxm1和ANGPTL4蛋白阳性表达率为63.89%和75.00%,明显高于对照组(P<0.05);FIGO分期Ⅱ期、肌层浸润≥1/2、中低分化宫颈癌Foxm1蛋白阳性表达率分别为89.47%、84.62%和79.07%,明显高于Ⅰ期、肌层浸润<1/2、高分化患者(P<0.05);有脉管浸润宫颈癌ANGPTL4蛋白阳性表达率为95.24%,明显高于无脉管浸润(P<0.05);Foxm1与ANGPTL4蛋白表达呈正相关(rs=0.301,P<0.05)。结论:宫颈癌组织中Foxm1、ANGPTL4蛋白呈高表达,在疾病发生发展中可能有重要作用。 Objective: To investigate the expression and clinical significance of Foxm1 and ANGPTL4 in cervical cancer. Methods:From January 2017 to March 2018, 72 specimens of cervical cancer and 35 specimens of normal cervical tissue were selected as controls;the expression of Foxm1 and ANGPTL4 protein was detected by immunohistochemical staining. Results: The positive rates of Foxm1 and ANGPTL4 protein in cervical cancer tissues were 63.89% and 75.00%, which were significantly higher than those in the control group(P< 0.05);The positive expression rates of Foxm1 protein in stage II, myometrial invasion ≥ 1/2, and moderately and poorly differentiated cervical cancer were 89.47%, 86.84% and 79.07% respectively, which were significantly higher than those in stage I, myometrial invasion <1/2 and well differentiated patients(P<0.05);The positive expression rate of ANGPTL4 protein in cervical carcinoma with vascular invasion was 95.24%, which was significantly higher than that without vascular invasion(P<0.05);We found a positive correlation between Foxm1 and ANGPTL4 protein expression(rs=0.301, P < 0.05). Conclusion: Foxm1 and ANGPTL4 proteins are highly expressed in cervical cancer tissues, and may play an important role in the development of diseases.
作者 陈辉 樊茹佳 丁继侠 CHEN Hui;FAN Ru-jia;DING Ji-xia(Department of Obstetrics and Gynecology,Henan University of Technology Hospital,Zhengzhou 450001,China;Department of Obstetrics and Gynecology,Henan People’s Hospital,Zhengzhou 450003,China)
出处 《天津医科大学学报》 2019年第5期510-513,共4页 Journal of Tianjin Medical University
基金 2016年度河南省医学科技攻关计划项目(201602184)
关键词 宫颈癌 FOXM1 ANGPTL4 临床意义 cervical cancer Foxm1 ANGPTL4 clinical significance
  • 相关文献

参考文献14

二级参考文献87

  • 1朱洪新,李锦军,覃文新,杨艳华,何祥火,万大方,顾健人.新基因ANGPTL4的克隆及其在血管新生中的功能研究[J].中华医学杂志,2002,82(2):94-99. 被引量:20
  • 2Chargue R, Damak T, Khomsi F, et al. Prognostic factors and clinicop- thologic characteristics of invasive adenocareinoma of the uterine cer- vix[J]. Am J Obstet Gynecol,2006,194( 1 ) :43 -48.
  • 3Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pat- tern of pelvic and paraaortic lymph node metastasis in stages I B, lI A and 1I B cervical carcinoma treated with radical hysterectomy [ J ]. Cancer, 1999 85 (7) : 1547 - 1554.
  • 4Kim SM, Choi HS, Bym JS. Overall 5 - year survival rate and prognos- tic factors in patients with stage I B and II A cervical cancer treated by radical hysterectomy and pelvic lymph node dissection [ J ]. Int J Gynecol Cancer,2000,10(4):305 -312.
  • 5Covens A, Rosen B, Murphy J, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix [ J ]. Gynecologic Oncology,2002,84( 1 ) : 145 - 149.
  • 6Plotti F, Sansone M, Di Donato V, et al. Quality of life and sexual function after typec2/type Ill radical hysterectomy for locally ad-vanced cervical cancer, a prospective study[ J]. The Joumal of Sexual Medicine,2010,8(3) :894 - 904.
  • 7Photopoulos GJ. Vander Zwaag R. Class 1] radical hysterectomy shows less morbidity and good treatment efficacy compared to class HI [J]. Gynecul Onco1,1991,40( 1 ) :21 -24.
  • 8Magrina JF,Goodrich MA,Weaver AL,et al. Modified radical hysterecto- my:morbidity and mortality[ J ]. Gynecol Oncol, 1995,59(2) :277 - 282.
  • 9Piver MS, Rutledge F, Smith J. Five classes of extended hysterectomy for women with cervical cancer[ J]. Obstet Gynecol, 1974,44 ( 2 ) : 265 - 272.
  • 10A1-Kalbani M, Mc Veigh G, Nagar H, et al. Do FIGO stage I A and small( ~2 cm) I B1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery? [ J]. Int J Gynecol Cancer,2012,22 (2) :291 -295.

共引文献342

同被引文献29

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部